Correlation Between Sharps Technology and Dermata Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sharps Technology and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sharps Technology and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sharps Technology and Dermata Therapeutics, you can compare the effects of market volatilities on Sharps Technology and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sharps Technology with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sharps Technology and Dermata Therapeutics.

Diversification Opportunities for Sharps Technology and Dermata Therapeutics

-0.35

Correlation Coefficient

Sharps Technology  Dermata Therapeutics

Very good diversification

The 3 months correlation between Sharps and Dermata is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Sharps Technology and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Sharps Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sharps Technology are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Sharps Technology i.e., Sharps Technology and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Sharps Technology and Dermata Therapeutics

Given the investment horizon of 90 days Sharps Technology is expected to under-perform the Dermata Therapeutics. In addition to that, Sharps Technology is 1.46 times more volatile than Dermata Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  17,400  in Dermata Therapeutics on May 4, 2025 and sell it today you would lose (16,755) from holding Dermata Therapeutics or give up 96.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sharps Technology  vs.  Dermata Therapeutics

Sharps Technology

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sharps Technology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Sharps Technology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Dermata Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Sharps Technology and Dermata Therapeutics

The main advantage of trading using opposite Sharps Technology and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sharps Technology position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.

The idea behind Sharps Technology and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.